33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1 mutations and prevents AML development
    Meeting Abstract

    Uckelmann, H. J.; Kim, S. M.; Antonissen, N. J. C.; Krivtsov, A. V.; Hatton, C.; McGeehan, G. M.; Levine, R. L.; Vassiliou, G. S.; Armstrong, S. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Hematologic malignancies arising in patients with germ cell tumors: Secondary somatic differentiation of hematopoietic malignancies from germ cell precursors
    Meeting Abstract

    Taylor, J.; Donoghue, M.; Rampal, R. K.; Tamari, R.; Tallman, M. S.; Feldman, D. R.; Taylor, B. S.; Abdel-Wahab, O. I.
    Blood (2018)

    Fulltext@MSK | Save
  • Selinexor, a first-in-class XPO1 inhibitor, is efficacious and tolerable in patients with myelodysplastic syndromes refractory to hypomethylating agents
    Meeting Abstract

    Taylor, J.; Coleman, M.; Alvarez, K.; Pichardo, J.; Sen, F.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; Tallman, M. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Functional profiling of patient AML stem cells reveals mechanisms of epigenetic plasticity controlling therapy resistance
    Meeting Abstract

    Takao, S.; Koche, R.; Cifani, P.; Ser, Z.; Kentsis, A.
    Blood (2018)

    Fulltext@MSK | Save
  • Chronic lymphocytic leukemia (CLL) transformed into Hodgkin lymphoma (HL): Clinical characteristics and outcomes from a large multi-center collaboration
    Meeting Abstract

    Stephens, D. M.; Boucher, K.; Kander, E.; Parikh, S. A.; Parry, E.; Shadman, M.; Pagel, J. M.; Cooperrider, J.; Rhodes, J.; Mato, A. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin lymphoma demonstrates limitations of PET-adapted approach
    Meeting Abstract

    Stephens, D. M.; Li, H.; Schoder, H.; Straus, D. J.; Moskowitz, C. H.; Leblanc, M. L.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Genomic landscape impacts induction outcome with CPX-351 in patients with acute myeloid leukemia
    Meeting Abstract

    Talati, C.; Goldberg, A. D.; Desai, P.; Chan, O.; Famulare, C.; Komrokji, R. S.; Kuykendall, A. T.; Fernandez, H. F.; Deutsch, Y. E.; Padron, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal enterococcus is a major risk factor for the development of acute GVHD
    Meeting Abstract

    Stein-Thoeringer, C. K.; Peled, J. U.; Gomes, A. L. C.; Lazrak, A.; Docampo, M. D.; Slingerland, A. E.; Nichols, K.; Shono, Y.; Weber, D.; Sung, A. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Safe and effective use of rivaroxaban for treatment of cancer associated venous thromboembolic disease
    Meeting Abstract

    Soff, G. A.; Sarasohn, D. M. M.; Haegler-Laube, E. S.; Devlin, S. M.; Miao, Y.; Bendheim, G.; Batista, J.; Wills, J.; Mones, J. V.; Wilkins, C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Ivosidenib or enasidenib combined with induction and consolidation chemotherapy in patients with newly diagnosed AML with an IDH1 or IDH2 mutation is safe, effective, and leads to MRD-negative complete remissions
    Meeting Abstract

    Stein, E. M.; DiNardo, C. D.; Fathi, A. T.; Mims, A. S.; Pratz, K. W.; Savona, M. R.; Stein, A. S.; Stone, R. M.; Winer, E. S.; Seet, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save